BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17848635)

  • 1. Fibroblast growth factor-2 in hyperplastic pituitaries of D2R knockout female mice.
    Cristina C; Díaz-Torga G; Góngora A; Guida MC; Perez-Millán MI; Baldi A; Becu-Villalobos D
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1341-51. PubMed ID: 17848635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
    Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D
    Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice.
    Cristina C; Díaz-Torga G; Baldi A; Góngora A; Rubinstein M; Low MJ; Becú-Villalobos D
    Endocrinology; 2005 Jul; 146(7):2952-62. PubMed ID: 15817666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas.
    Luque GM; Perez-Millán MI; Ornstein AM; Cristina C; Becu-Villalobos D
    J Pharmacol Exp Ther; 2011 Jun; 337(3):766-74. PubMed ID: 21406548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin.
    García-Tornadú I; Rubinstein M; Gaylinn BD; Hill D; Arany E; Low MJ; Díaz-Torga G; Becu-Villalobos D
    J Endocrinol; 2006 Sep; 190(3):611-9. PubMed ID: 17003262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice.
    Asa SL; Kelly MA; Grandy DK; Low MJ
    Endocrinology; 1999 Nov; 140(11):5348-55. PubMed ID: 10537166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic D2 receptor knockout mouse: an animal model of prolactinoma.
    Cristina C; García-Tornadú I; Díaz-Torga G; Rubinstein M; Low MJ; Becú-Villalobos D
    Front Horm Res; 2006; 35():50-63. PubMed ID: 16809922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of insulin-like growth factor-I for the regulation of prolactin synthesis by estrogen and postnatal proliferation of lactotrophs in the mouse anterior pituitary.
    Saitoh Y; Hikake T; Hayashi S; Iguchi T; Sato T
    Cell Tissue Res; 2010 Apr; 340(1):147-58. PubMed ID: 20198387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
    Pisarek H; Stepien H; Pawlikowski M
    Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian dependence for pituitary tumorigenesis in D2 dopamine receptor-deficient mice.
    Hentges ST; Low MJ
    Endocrinology; 2002 Dec; 143(12):4536-43. PubMed ID: 12446580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic orexin, OX1, alphaMSH, NPY and MCRs expression in dopaminergic D2R knockout mice.
    García-Tornadú I; Díaz-Torga G; Risso GS; Silveyra P; Cataldi N; Ramirez MC; Low MJ; Libertun C; Becu-Villalobos D
    Neuropeptides; 2009 Aug; 43(4):267-74. PubMed ID: 19570576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine-induced locomotor activity and cocaine discrimination in dopamine D2 receptor mutant mice.
    Chausmer AL; Elmer GI; Rubinstein M; Low MJ; Grandy DK; Katz JL
    Psychopharmacology (Berl); 2002 Aug; 163(1):54-61. PubMed ID: 12185400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystathionine gamma-lyase deficiency and overproliferation of smooth muscle cells.
    Yang G; Wu L; Bryan S; Khaper N; Mani S; Wang R
    Cardiovasc Res; 2010 Jun; 86(3):487-95. PubMed ID: 20051385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the endocrine and metabolic roles of dopamine D2 receptors gained from the Drd2 mouse.
    Garcia-Tornadú I; Perez-Millan MI; Recouvreux V; Ramirez MC; Luque G; Risso GS; Ornstein AM; Cristina C; Diaz-Torga G; Becu-Villalobos D
    Neuroendocrinology; 2010; 92(4):207-14. PubMed ID: 20975260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor-2 is an immediate-early gene induced by mechanical stress in osteogenic cells.
    Li CF; Hughes-Fulford M
    J Bone Miner Res; 2006 Jun; 21(6):946-55. PubMed ID: 16753025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative effect of E₂ and FGF2 on lactotroph proliferation triggered by signaling initiated at the plasma membrane.
    Sosa Ldel V; Gutiérrez S; Petiti JP; Vaca AM; De Paul AL; Torres AI
    Am J Physiol Endocrinol Metab; 2013 Jul; 305(1):E41-9. PubMed ID: 23651845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laminin inhibits lactotroph proliferation and is reduced in early prolactinoma development.
    Kuchenbauer F; Theodoropoulou M; Hopfner U; Stalla J; Renner U; Tonn JC; Low MJ; Arzt E; Stalla GK; Páez-Pereda M
    Mol Cell Endocrinol; 2003 Sep; 207(1-2):13-20. PubMed ID: 12972179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases.
    Wang C; Buck DC; Yang R; Macey TA; Neve KA
    J Neurochem; 2005 May; 93(4):899-909. PubMed ID: 15857393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of lactotrop proliferation by dopamine: essential role of signaling through D2 receptors and ERKs.
    Iaccarino C; Samad TA; Mathis C; Kercret H; Picetti R; Borrelli E
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14530-5. PubMed ID: 12391292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of neuromedin B receptor gene results in dysregulation of the pituitary-thyroid axis.
    Oliveira KJ; Ortiga-Carvalho TM; Cabanelas A; Veiga MA; Aoki K; Ohki-Hamazaki H; Wada K; Wada E; Pazos-Moura CC
    J Mol Endocrinol; 2006 Feb; 36(1):73-80. PubMed ID: 16461928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.